Introduction {#s1}
============

Benign paroxysmal positional vertigo (BPPV) is the most frequent vestibular disorder ([@B1]). It is caused by the abnormal stimulation of the cupula, upon changing head position, by otoconia, either floating or attached to the cupula, in any of the three semicircular canals. The Dix-Hallpike maneuver and the supine roll test are used to diagnose BPPV, and patients are treated through specific canalith-repositioning maneuvers, although remission can be expected within several days also without treatment ([@B2]). Among the semicircular canals, the posterior canal is the most affected for anatomical reasons. In the horizontal semicircular canal, canalolithiasis and cupulolithiasis exhibit the characteristic nystagmus: canalolithiasis leads to geotropic direction changing nystagmus lasting \<1 min, while cupulolithiasis shows apogeotropic direction changing nystagmus lasting more than 1 min, in the supine roll test ([@B3]). In addition, when the otoconia fall into the short arm and directly onto the cupula, apogeotropic horizontal nystagmus are observed (short-arm canalolithiasis) ([@B4]). No nystagmus may be provoked in the contralateral spine position because the otoconia may fall out during the spine roll test in the contralateral direction. Moreover, rapid transition from apogeotropic to geotropic direction changing nystagmus during the supine roll test may be observed when otoconia are located in the anterior part of the horizontal canal ([@B3]).

BPPV patients are at a high risk of fracture, associated with abnormal bone turnover ([@B5]). Vitamin D mainly controls the absorption of calcium and phosphate from the small intestine, which plays a crucial role in bone turnover ([@B6]). On the other hand, vitamin D deficiency can change the structure of the otoconia, which are made of calcium carbonate ([@B7]). Such structural changes may induce otoconia to easily detach from the otolith organ, leading to BPPV attacks. No studies have compared serum levels of vitamin D between canalolithiasis and cupulolithiasis patients, which we focused on.

The purpose of this study was to clarify the difference in vitamin D serum level between canalolithiasis and cupulolithiasis of the horizontal canal. The results will contribute to explain the pathophysiological difference between canalolithiasis and cupulolithiasis.

Materials and Methods {#s2}
=====================

Participants
------------

Patients who visited the National Center for Geriatrics and Gerontology between May 2017 and September 2018 and were diagnosed with horizontal canal canalolithiasis or cupulolithiasis, according to the criteria established by the Barany Society ([@B3]) were included in the study. Blood samples were collected when the patients visited the hospital outpatient department with a vertigo attack. The serum level of 25-hydroxyvitamin D \[25(OH)D\], the main indicator of vitamin D status, was measured from the samples using a chemiluminescence immunoassay (BML Inc., Japan).

Statistical Analyses
--------------------

Statistical analysis was carried out with the Statistical Analysis System (SAS) package, version 9.3 (SAS Institute, Cary, NC, USA). The difference in the mean level of serum 25 hydroxyvitamin D between the groups was assessed using a general linear model to adjust for age and sex. A serum 25(OH)D level of \<20 ng/mL was defined as vitamin D deficiency. The relationship between the diagnosis (canalolithiasis or cupulolithiasis) and vitamin D deficiency (\<20 ng/mL) was assessed using the chi squared test and logistic regression. The level of significance was set at *p* \< 0.05.

Results {#s3}
=======

A total of 38 patients were diagnosed with BPPV of the horizontal semicircular canal. Of these, 35 patients, followed up until the symptoms and nystagmus disappeared, were enrolled in the study, while 3 were excluded due to loss of follow up. Among the 35 participants, 20 were diagnosed with horizontal canal canalolithiasis (CAN), and 15 with horizontal canal cupulolithiasis (CUP). The age of the CAN group was 76.7 ± 7.1 years, with 17 females (85%), while that of the CUP group was 75.9 ± 5.4 years, with 6 females (40%). The difference in sex prevalence was statistically significant (*p* = 0.0055, [Table 1A](#T1){ref-type="table"}). The mean serum 25(OH)D level of in the CAN group was 13.2 ± 1.4 ng/mL \[least square (LS) mean ± standard error (SE)\] and that in the CUP group was 20.4 ± 1.6 ng/mL (LS means ± SE), a statistically significant difference (*p* = 0.0014, [Table 2](#T3){ref-type="table"}). After adjusting for age only, sex only, and for both using a general linear model, the level of 25(OH)D in the CAN group was still significantly lower than in the CUP group (*p* = 0.0018, *p* = 0.0274, and *p* = 0.0351, respectively, [Table 2](#T3){ref-type="table"}).

###### 

Number, sex, and age of the participants.

                   **Canalolithiasis**   **Cupulolithiasis**   ***p*-value**
  ---------------- --------------------- --------------------- -----------------------------------------
  Number           20                    15                    
  Female/male      17/3                  6/9                   0.0055[^\*^](#TN1){ref-type="table-fn"}
  Age, mean ± SD   76.7 ± 7.1            75.9 ± 5.4            0.695$5_{*}^{*}$

SD, standard deviation.

Chi squared test;

*$\ _{*}^{*}$t-test*.

###### 

Number of canalolithiasis/cupulolithiasis patients diagnosed with vitamin D deficiency. Vitamin D deficiency (serum level \< 20 ng/mL) was associated with the onset of a canalolithiasis (chi squared test, *p* = 0.0005).

                            **Canalolithiasis**   **Cupulolithiasis**
  ------------------------- --------------------- ---------------------
  Vitamin D deficiency      18                    5
  No vitamin D deficiency   2                     10

###### 

Serum level of vitamin D in patients with canalolithiasis and cupulolithiasis, and the covariates used in the general linear model.

  **Moderator variable**   **Serum level of vitamin D in *canalolithiasis* (ng/mL), LS means ± SE**   **Serum level of vitamin D in *cupulolithiasis* (ng/mL), LS means ± SE**   ***p*-value**
  ------------------------ -------------------------------------------------------------------------- -------------------------------------------------------------------------- ---------------
  no (base model)          13.2 ± 1.4                                                                 20.4 ± 1.6                                                                 0.0014
  age                      13.2 ± 1.4                                                                 20.4 ± 1.6                                                                 0.0018
  sex                      14.7 ± 1.6                                                                 19.9 ± 1.5                                                                 0.0274
  both age and sex         14.8 ± 1.6                                                                 19.9 ± 1.5                                                                 0.0351

LS, least square means; SE, standard error.

*Serum vitamin D levels were significantly lower in patients with canalolithiasis than those with cupulolithiasis using general linear model even adjusting by age, sex, or both*.

Vitamin D deficiency was diagnosed in 18 out of 20 patients (90%) in the CAN group and 5 out of 15 (33%) in the CUP group, and such difference was statistically significant (*p* = 0.0005; [Table 1B](#T2){ref-type="table"}).

Discussion {#s4}
==========

Several studies have reported the association of BPPV with vitamin D deficiency and impaired bone turnover ([@B8]--[@B12]), without however differentiating between canalolithiasis and cupulolithiasis. We showed that vitamin D serum level is lower in canalolithiasis of the horizontal canal than in cupulolithiasis of horizontal canal. Moreover, the number of female patients and of patients with vitamin D deficiency were higher in the CAN group compared to the CUP group. Females are more likely than males to be affected by vitamin D deficiency ([@B13]), but the significance of the difference between the two pathologies was preserved after statistically adjusting for sex.

Our previous study demonstrates that the patients with BPPV have a higher risk of fracture, calculated using the Fracture Risk Assessment Tool (FRAX) ([@B5]). Calcium is the main nutrient needed for bone development, and vitamin D controls the small bowel absorption of calcium and potassium. Serum levels of vitamin D are directly related to bone mineral turnover ([@B6]).

Otoconia are made from an inorganic calcium carbonate, calcite, deposited onto an organic matrix ([@B14]), therefore vitamin D deficiency can affect the structure of otoconia. Kao et al. extracted particulate matter from the posterior semicircular canal of two patients during posterior canal occlusion surgery, and examined them with scanning electron microscopy. They demonstrated that both intact and degenerate otoconia, most of which are interconnected with linking fibrils, associated with particulate matter within the semicircular canal of BPPV patients ([@B15]). Further study is needed to evaluate the effects of vitamin D deficiency on the structure of otoconia.

One limitation of this study is the relatively small sample size, which might compromise the generality of the results. However, the statistical significance of the results obtained with such a modest sample size demonstrates that the effect we revealed is quite sizeable.

In conclusion, the present study showed significantly lower vitamin D serum levels in patients with canalolithiasis of horizontal canal compared to those with cupulolithiasis, and vitamin D deficiency in 90% of the canalolithiasis patients. These results suggest the pathophysiological difference between canalolithiasis and cupulolithiasis. In patients with BPPV, and especially with canalolithiasis, a possible vitamin D deficiency should be considered. The early detection of osteoporosis or osteopenia in patients with BPPV would prevent osteoporotic fractures and BPPV recurrence. Further research is however needed to assess the generality of our results.
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